Dr. Reddy’s vs Lupin: share price, P/E, ROE and financials compared
Dr. Reddy's Laboratories
Lupin
Dr. Reddy’s and Lupin at a glance
Dr. Reddy’s and Lupin are both listed in Healthcare. Dr. Reddy’s is the larger by market cap, at ₹1.1L Cr against ₹90,914 Cr for Lupin (1.3 times as large). On valuation, Dr. Reddy’s has the lower price-to-book (2.96× against 3.78×), while Lupin has the lower P/E (17.5× against 40.9×). On returns and margins, Lupin has the higher ROCE (28.3% against 14.2%), the higher ROE (23.9% against 7.3%) and the higher operating margin (28.9% against 15.9%). Over three years, Lupin has faster 3-year sales growth (+19.1% against +11.0% a year) and faster 3-year profit growth (+131.4% against −1.7% a year). Dr. Reddy’s carries less debt for its equity, with a debt-to-equity of 0.19× against 0.26×.
Key metrics, side by side
| Metric | Dr. Reddy’sDRREDDY | LupinLUPIN |
|---|---|---|
| Price (₹) | 1,373.00 | 1,988.10 |
| Market cap (₹ Cr) | 1,14,462 | 90,914 |
| P/E | 40.9× | 17.5× (the lower figure, shaded) |
| P/B | 2.96× (the lower figure, shaded) | 3.78× |
| Dividend yield, trailing | 0.58% | 0.91% (the higher figure, shaded) |
| ROE | 7.3% | 23.9% (the higher figure, shaded) |
| ROCE | 14.2% | 28.3% (the higher figure, shaded) |
| Operating margin (OPM) | 15.9% | 28.9% (the higher figure, shaded) |
| Net margin (NPM) | 8.5% | 16.9% (the higher figure, shaded) |
| Sales CAGR 3Y | +11.0% | +19.1% (the higher figure, shaded) |
| Profit CAGR 3Y | −1.7% | +131.4% (the higher figure, shaded) |
| Debt to equity | 0.19× (the lower figure, shaded) | 0.26× |
| Interest cover | 15.7× | 17.7× (the higher figure, shaded) |
| Net profit TTM (₹ Cr) | 2,799 | 5,206 |
| 1Y return | +13.8% (the higher figure, shaded) | −0.5% |
| Promoter holding | 26.63% | 46.84% |
Dr. Reddy’s vs Lupin: common questions
Which is bigger, Dr. Reddy’s or Lupin?
By market cap, Dr. Reddy’s is bigger at ₹1.1L Cr, against ₹90,914 Cr for Lupin (prices as of 6 Nov 2026). Net profit over the last twelve months was ₹2,799 Cr for Dr. Reddy’s and ₹5,206 Cr for Lupin.
Which has a lower P/E ratio, Dr. Reddy’s or Lupin?
Dr. Reddy’s trades at a P/E of 40.9× and Lupin at 17.5×. Lupin has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Dr. Reddy’s or Lupin?
Dr. Reddy’s reports a return on equity of 7.3% and Lupin 23.9%. Lupin has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Dr. Reddy’s or Lupin?
Over the last three years: Sales grew +11.0% a year at Dr. Reddy’s and +19.1% at Lupin, so Lupin grew sales faster; profit grew −1.7% a year at Dr. Reddy’s and +131.4% at Lupin, so Lupin grew profit faster. Past growth doesn’t predict future growth.